Literature DB >> 9545404

Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3.

H Tamary1, L Shalmon, H Shalev, A Halil, D Dobrushin, N Ashkenazi, M Zoldan, P Resnitzky, M Korostishevsky, B Bonne-Tamir, R Zaizov.   

Abstract

Congenital dyserythropoietic anemias (CDA) are a rare group of red-blood-cell disorders of unknown etiology that are characterized by ineffective erythropoiesis, pathognomonic cytopathology of the nucleated red blood cells in the bone marrow, and secondary hemochromatosis. In CDA type I, bone-marrow electron microscopy reveals characteristic findings in erythroid precursors, including spongy heterochromatin and enlarged nuclear pores. Since the genetic basis of CDA type I is not evident, we used homozygosity and linkage mapping to localize the genetic defect responsible for CDA type I in 25 Bedouins from four large consanguineous families. We report the linkage of this disease to markers on chromosome 15 located at q15. 1-q15.3. Fourteen markers within a 12-cM interval were typed in the relevant family members. Nine of the markers yielded maximum LOD scores of 1.625-12.928 at a recombination fraction of .00. Linkage disequilibrium was found only with marker D15S779. Haplotype analysis revealed eight different carrier haplotypes and highlighted the existence of a founder haplotype. Identification of historical crossover events further narrowed the gene location to between D15S779 and D15S778. The data suggest localization of the CDA type I gene within a 0.5-cM interval. The founder mutation probably occurred >/= 400 years ago. Sequence analysis of the coding region of protein 4.2, the only known erythroid-specific gene in the locus, did not reveal any change in the CDA type I patients. Future analysis of this locus may lead to the identification of a gene essential to normal erythropoiesis.

Entities:  

Mesh:

Year:  1998        PMID: 9545404      PMCID: PMC1377091          DOI: 10.1086/301834

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search.

Authors:  P Gasparini; E Miraglia del Giudice; J Delaunay; A Totaro; M Granatiero; S Melchionda; L Zelante; A Iolascon
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

2.  The gene for human erythrocyte protein 4.2 maps to chromosome 15q15.

Authors:  V Najfeld; S G Ballard; J Menninger; D C Ward; E E Bouhassira; R S Schwartz; R L Nagel; A C Rybicki
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

Review 3.  Dyserythropoiesis and congenital dyserythropoietic anaemias.

Authors:  S N Wickramasinghe
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

4.  Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the a subunit of factor XIII.

Authors:  C Korsgren; C M Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies.

Authors:  J Ott
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

6.  Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts.

Authors:  H Heimpel; F Wendt
Journal:  Helv Med Acta       Date:  1968-03

7.  Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes.

Authors:  M Poncz; D Solowiejczyk; B Harpel; Y Mory; E Schwartz; S Surrey
Journal:  Hemoglobin       Date:  1982       Impact factor: 0.849

8.  Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25.

Authors:  L Lind; H Sandström; A Wahlin; M Eriksson; B Nilsson-Sojka; C Sikström; G Holmgren
Journal:  Hum Mol Genet       Date:  1995-01       Impact factor: 6.150

9.  Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children.

Authors:  E S Lander; D Botstein
Journal:  Science       Date:  1987-06-19       Impact factor: 47.728

10.  Incompletely processed N-glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS).

Authors:  M N Fukuda; G F Gaetani; P Izzo; P Scartezzini; A Dell
Journal:  Br J Haematol       Date:  1992-12       Impact factor: 6.998

View more
  5 in total

1.  Close to unraveling the secrets of congenital dyserythropoietic anemia types I and II.

Authors:  Achille Iolascon; Jean Delaunay
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

2.  Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.

Authors:  Orly Dgany; Nili Avidan; Jean Delaunay; Tatyana Krasnov; Lea Shalmon; Hanna Shalev; Tal Eidelitz-Markus; Joseph Kapelushnik; Daniel Cattan; Alexandre Pariente; Michel Tulliez; Aurore Crétien; Pierre-Olivier Schischmanoff; Achille Iolascon; Eithan Fibach; Ariel Koren; Jochen Rössler; Martine Le Merrer; Isaac Yaniv; Rina Zaizov; Edna Ben-Asher; Tsvyia Olender; Doron Lancet; Jacques S Beckmann; Hannah Tamary
Journal:  Am J Hum Genet       Date:  2002-11-14       Impact factor: 11.025

3.  Congenital dyserythropoietic anemia.

Authors:  Takahiro Kamiya; Atsushi Manabe
Journal:  Int J Hematol       Date:  2010-09-07       Impact factor: 2.490

4.  Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.

Authors:  Sharon Noy-Lotan; Orly Dgany; Roxane Lahmi; Nathaly Marcoux; Tanya Krasnov; Nissan Yissachar; Doron Ginsberg; Benny Motro; Peretz Resnitzky; Isaac Yaniv; Gary M Kupfer; Hannah Tamary
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

Review 5.  Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

Authors:  Achille Iolascon; Maria Rosaria Esposito; Roberta Russo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.